Active

Uncovering how the tumour microenvironment can make cancer cells more aggressive

Cancer types:

Head & neck cancer

Project period:

Research institute:

Consejo Superior Investigaciones Cientificas and Universidad Autonoma de Madrid (CSIC-UAM)

Award amount:

£166,604

Location:

Spain

Leandro Sastre Garzon Headshot
Researcher Professor Leandro Sastre Garzón

Professor Sastre Garzón and his team are studying how oral cancer cells gain the ability to spread into other tissues. They hope to find ways to prevent metastasis or treat cancer that has already spread.

Hope for the future

Most cancer deaths are ultimately caused my metastasis, where cells spread from the original tumour to other places around the body. Cancer cells often change and gain the ability to spread, and they can be influenced to do so by the environment around them in the tumour. 

Professor Sastre Garzón and his team are studying how the tumour microenvironment influences oral cancer cells to change, giving them the ability to spread to other places in the body. They hope that uncovering this process will reveal new ways to treat cells that have already spread, or even prevent it happening. 

Leandro Sastre Garzon and Team
Meet the scientist

Professor Sastre Garzón started working in cancer hoping to apply his experience in other areas of biology to a big problem for society – he is supported by his wife and daughter, both of whom are also cancer researchers! Outside of the lab, he enjoys reading and learning about history, and has one dog, two cats, and a variety of plants at home.

The science

Tumours are not just a bundle of identical cancer cells; in fact, they are complex ecosystems made up of cancer cells and many other types of cell. Together they form something called a tumour microenvironment. In a similar way to how soil nurtures plants to grow, the tumour microenvironment helps the tumour to grow and spread. 

In oral cancer, a type of head and neck cancer, the main cells in the tumour microenvironment that influence this change are cancer-associated fibroblasts (CAFs). They disrupt the cellular machinery that reads instructions off DNA. This causes the cancer cells to change and gives them the ability to spread into surrounding tissue through the ‘soil’ and colonise other areas. 

Professor Sastre Garzón and his team want to understand how the CAFs communicate with the cancer cells to cause that change. They hope that unpicking this process will reveal new ways to prevent this spread happening or destroy the cells that have already spread. 

I believe that science is a major driver of the advance of our society. I think this is the case in many fields and also in biomedical sciences. Discovery research is basic in this advance as shown in many social and medical improvements that followed discovery research findings.

Leandro Sastre Garzon Headshot
Professor Leandro Sastre Garzón

You might also be interested in:

Clare Isacke Team Photo

Active United Kingdom

Sarcoma

Can one cure work for multiple sarcoma types?

Dr Clare Isacke is investigating a potentially game-changing way to treat sarcoma. A new targeted treatment could work on many different types of sarcoma, giving hope to patients around the world. 

Researcher: Professor Clare Isacke

Can one cure work for multiple sarcoma types?

Active United Kingdom

Prostate cancer

Reinforcing Radiotherapy: can we find new prostate cancer treatment combinations?

Thanks to, curestarter donations, Dr Luke Gaughan and his team in Newcastle are looking for ways to help radiotherapy work better for more prostate cancer patients. They are exploring a potential new cure and working out which other treatments it could team up with best to attack prostate cancer. 

Researcher: Dr Luke Gaughan

Reinforcing Radiotherapy: can we find new prostate cancer treatment combinations?

Active United Kingdom

Oesophageal cancer

Could we detect treatment resistance in oesophagogastric cancer before it even begins?

Dr Eileen Parkes and her team in Oxford want to better understand the genetics of a very aggressive type of oesophagogastric cancer. They hope they will find a way to tell how and when a cancer will become resistant to treatment and most crucially how to overcome this resistance. 

Researcher: Dr Eileen Parkes

Could we detect treatment resistance in oesophagogastric cancer before it even begins?

Donate today to start new cures

Be part of the united effort to stop lives being cut short by cancer.

Share this page